EpCAM participates as a cell adhesion and cell signaling molecule, and its overexpression negatively correlates with survival rates in gallbladder cancer, ampullary carcinoma, and squamous cell carcinoma (SCC) of the head and neck [4,7]. Here, EPCAM is linked to squamous cell carcinoma.